European Innovation Council (EIC)

Hero top shape asset
Hero ImageEuropean Innovation Council (EIC)
Hero Radius Shape
Hero bottom shape asset
Hero top shape asset
Hero ImageEuropean Innovation Council (EIC)
Hero Radius Shape
Hero bottom shape asset

Transition Grant

Clarity Sensors is delighted to be the recipient of a €2.5 EIC Transition grant in May 2025. The EIC Transition grant is a program under Horizon Europe 
that provides funding and support to advance innovative technologies from a lab-based proof-of-concept to a market-ready stage. It bridges the gap between early-stage research and later commercialization by funding activities like prototypingmodeling, and validation in real-world environments. The grant also supports business development to ensure the technology has a viable path to market, with funding of up to €2.5 million available.

Previously The Stranks Lab (at University of Cambridge, Department of Chemical Engineering & Biotechnology) were recipients of grants from Horizon Europe for development of perovskite photon-counting detectors based on halide perovskites, which successfully demonstrated their potential to be high performing and cost-effective X-ray detectors.

In the PERFORM project, Clarity Sensors, is developing advanced photon-counting detectors with halide perovskite semiconductors. Our patented monolithic integration process, combined with leading perovskite quality, positions Clarity Sensors to deliver industry-leading photon-counting detectors, targeting the highest image resolution and lowest effective dose, enabling 100 times more scans at the same radiation level.
Through projects such as our ERC Proof-of-Concept (PEROVSCI), we have demonstrated a stable, single-pixel halide perovskite PCD and filed key IP culminating in the fabrication of the first monolithic perovskite PCD on a multi-pixel ASIC. In PERFORM, we will further develop our technology and business operations to position Clarity Sensors for investment and joint development. This will include optimising our current PCD systems and developing our working demonstrator, PRISM-X, which will be validated against commercial technologies in clinical settings to reach TRL5.

Details of the PERFORM project can be found here.